Search Results

Sarah Cannon Research Institute announced a collaboration with Tennessee Cancer Specialists, an independent, private practice oncology group, based in Knoxville, Tenn.

The board of directors of The University of Tennessee Medical Center has selected Dr. Keith Gray as president and chief executive officer, effective April 1, 2024.

Centinel Spine®, LLC (“the Company”) today announced significant expansion of coverage for lumbar TDR procedures in Tennessee.

ChromaCode, Inc. today announced the signing of an early access agreement with Tennessee Oncology, a nationally recognized oncology practice with 35 clinical sites of care across Tennessee and in Northwest Georgia, to test the analytical and clinical performance of ChromaCode’s HDPCR non-small cell lung cancer (NSCLC) biomarker assay.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

The University of Tennessee Health Science Center (UTHSC), oncology drug discovery research partner to Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for SARS-CoV-2 and other viral ARDS-related diseases, has secured two additional grants to develop oncology therapeutics for indications of high unmet need.

Leading health and well-being company Humana Inc. announced that, for the third consecutive year and the fourth time overall, its statewide Humana HMO Medicare Advantage plan in Tennessee has achieved the highest possible 5-star rating from the Centers for Medicare & Medicaid Services.

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize health care, announced that The University of Tennessee Medical Center’s Cancer Institute has joined Caris’ Precision Oncology Alliance™.